Srikanth Mahavadi, DPM
NPI 1487610341 · Foot Surgery Podiatrist · Providence Forge, VA
Enrolled with Medicare as Practitioner - Podiatry · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1487610341
- Entity type
- Individual
- Primary specialty
- Foot Surgery PodiatristPodiatric Medicine & Surgery Service Providers
- Credential
- DPM
- Sex
- Male
- Sole proprietor
- No
- License
- 0103001025 (VA)
Specialties & taxonomies
Podiatric Medicine & Surgery Service Providers
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
20 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
2,010 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Removal of Muscle And/Or Tissue, Each Additional 20.0 Sq Cm Or Less11046 | 433 | $48 |
| Removal of Fingernails Or Toenails, 1-5 Nails11720 | 318 | $30 |
| Removal of Noncancer Thickened Skin Growth, 2-4 Growths11056 | 201 | $75 |
| Removal of Fingernails Or Toenails, 6 Or More Nails11721 | 184 | $40 |
| Removal of Muscle And/Or Tissue, 20.0 Sq Cm Or Less11043 | 157 | $134 |
| Removal of Skin and Tissue, 20.0 Sq Cm Or Less11042 | 131 | $52 |
| Removal of Noncancer Thickened Skin Growth, 1 Growth |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 8 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Gabapentin | 36 | — |
| Mupirocin | 36 | 23 |
| Cephalexin | 32 | 25 |
| Doxycycline Hyclate | 32 | 26 |
| Neomycin/Polymyxin B/Hydrocortbrand: Neomycin-Polymyxin-Hc | 29 | 21 |
| Ciclopirox Olaminebrand: Ciclopirox | 23 | — |
| Hydrocodone/Acetaminophenbrand: Hydrocodone-Acetaminophen | 22 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$1,267 across 36 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2006-04-20
- Last updated
- 2007-07-08
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.